Matthew Beard

1.5k total citations
39 papers, 1.2k citations indexed

About

Matthew Beard is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew Beard has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 14 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew Beard's work include Botulinum Toxin and Related Neurological Disorders (23 papers), Neurological disorders and treatments (18 papers) and Cellular transport and secretion (10 papers). Matthew Beard is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (23 papers), Neurological disorders and treatments (18 papers) and Cellular transport and secretion (10 papers). Matthew Beard collaborates with scholars based in France, United Kingdom and United States. Matthew Beard's co-authors include Miles D. Houslay, Graham Warren, James Shorter, Ayano Satoh, Ian McPhee, A. Barbara Dirac-Svejstrup, Joachim Seemann, Graeme B. Bolger, Elaine Huston and Grant Scotland and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Matthew Beard

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Beard France 16 884 377 268 223 205 39 1.2k
Yakup Batlevi United States 6 878 1.0× 334 0.9× 66 0.2× 288 1.3× 251 1.2× 7 1.4k
Eszter Zavodszky United Kingdom 12 743 0.8× 480 1.3× 53 0.2× 191 0.9× 231 1.1× 15 1.3k
Helen I. Woodroof United Kingdom 7 734 0.8× 234 0.6× 32 0.1× 143 0.6× 508 2.5× 7 1.2k
Woo‐Joo Song South Korea 16 565 0.6× 164 0.4× 39 0.1× 76 0.3× 39 0.2× 18 947
Boonlert Cheewatrakoolpong United States 12 297 0.3× 64 0.2× 41 0.2× 91 0.4× 163 0.8× 20 732
Sergey S. Novoselov United Kingdom 14 751 0.8× 306 0.8× 37 0.1× 296 1.3× 305 1.5× 20 1.0k
Mei Kwan Canada 9 611 0.7× 61 0.2× 52 0.2× 356 1.6× 141 0.7× 14 897
Yanqiu Zheng United States 8 347 0.4× 104 0.3× 25 0.1× 77 0.3× 554 2.7× 12 925
Michel Mohr France 17 510 0.6× 104 0.3× 61 0.2× 157 0.7× 207 1.0× 33 899
Sarah van Veen Belgium 11 369 0.4× 145 0.4× 49 0.2× 62 0.3× 220 1.1× 13 647

Countries citing papers authored by Matthew Beard

Since Specialization
Citations

This map shows the geographic impact of Matthew Beard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Beard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Beard more than expected).

Fields of papers citing papers by Matthew Beard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Beard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Beard. The network helps show where Matthew Beard may publish in the future.

Co-authorship network of co-authors of Matthew Beard

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Beard. A scholar is included among the top collaborators of Matthew Beard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Beard. Matthew Beard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tay, Felicia P., Omar Loss, Laurent Pons, et al.. (2024). Botulinum toxin intoxication requires retrograde transport and membrane translocation at the ER in RenVM neurons. eLife. 12. 1 indexed citations
2.
Martínez‐Carranza, Markel, Jana Škerlová, Pyung‐Gang Lee, et al.. (2024). Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin protein. Communications Chemistry. 7(1). 179–179. 5 indexed citations
3.
Retailleau, Kevin, et al.. (2024). A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling. Toxins. 16(1). 30–30. 1 indexed citations
4.
Sikorra, Stefan, Sarah Donald, Mark Elliott, et al.. (2020). Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant. Toxins. 12(12). 804–804. 5 indexed citations
5.
Elliott, Mark, Sai Liu, Geoffrey Masuyer, et al.. (2019). Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models. Science Advances. 5(1). eaau7196–eaau7196. 33 indexed citations
6.
Elliott, Mark, et al.. (2018). The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent. Toxicology in Vitro. 48. 255–261. 4 indexed citations
7.
Tao, Liang, Lisheng Peng, Ronnie P.‐A. Berntsson, et al.. (2017). Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors. Nature Communications. 8(1). 53–53. 45 indexed citations
8.
Elliott, Mark, et al.. (2017). Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems. PLoS ONE. 12(10). e0185628–e0185628. 12 indexed citations
9.
Shirai, Mikiyasu, Matthew Beard, James T. Pearson, et al.. (2013). Impaired pulmonary blood flow distribution in congestive heart failure assessed using synchrotron radiation microangiography. Journal of Synchrotron Radiation. 20(3). 441–448. 3 indexed citations
10.
Masuyer, Geoffrey, Ian Birch‐Machin, Matthew Beard, et al.. (2011). Engineering botulinum neurotoxin domains for activation by toxin light chain. FEBS Journal. 279(3). 515–523. 11 indexed citations
11.
Masuyer, Geoffrey, et al.. (2010). Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B. Journal of Structural Biology. 174(1). 52–57. 15 indexed citations
12.
Mayer, Thomas U., Bernd Jagla, Michael R. Wyler, et al.. (2006). Cell‐Based Assays Using Primary Endothelial Cells to Study Multiple Steps in Inflammation. Methods in enzymology on CD-ROM/Methods in enzymology. 414. 266–283. 8 indexed citations
13.
Satoh, Ayano, Matthew Beard, & Graham Warren. (2005). Preparation and Characterization of Recombinant Golgin Tethers. Methods in enzymology on CD-ROM/Methods in enzymology. 404. 279–296. 7 indexed citations
14.
Beard, Matthew, Ayano Satoh, James Shorter, & Graham Warren. (2005). A Cryptic Rab1-binding Site in the p115 TetheringProtein. Journal of Biological Chemistry. 280(27). 25840–25848. 71 indexed citations
15.
Satoh, Ayano, Yanzhuang Wang, Jörg Malsam, Matthew Beard, & Graham Warren. (2003). Golgin‐84 is a rab1 Binding Partner Involved in Golgi Structure. Traffic. 4(3). 153–161. 106 indexed citations
16.
17.
MacKenzie, Simon J., George S. Baillie, Ian McPhee, et al.. (2002). Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1). British Journal of Pharmacology. 136(3). 421–433. 215 indexed citations
18.
Beard, Matthew, et al.. (2000). UCR1 and UCR2 Domains Unique to the cAMP-specific Phosphodiesterase Family Form a Discrete Module via Electrostatic Interactions. Journal of Biological Chemistry. 275(14). 10349–10358. 105 indexed citations
19.
Beard, Matthew, Jonathan C. O’Connell, Graeme B. Bolger, & Miles D. Houslay. (1999). The unique N‐terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains. FEBS Letters. 460(1). 173–177. 56 indexed citations
20.
Scotland, Grant, Matthew Beard, Suat Erdoğan, et al.. (1998). Intracellular Compartmentalization of PDE4 Cyclic AMP-Specific Phosphodiesterases. Methods. 14(1). 65–79. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yakup Batlevi Breakdown of academic impact, for papers by Eszter Zavodszky Breakdown of academic impact, for papers by Helen I. Woodroof Breakdown of academic impact, for papers by Woo‐Joo Song Breakdown of academic impact, for papers by Boonlert Cheewatrakoolpong Breakdown of academic impact, for papers by Sergey S. Novoselov Breakdown of academic impact, for papers by Mei Kwan Breakdown of academic impact, for papers by Yanqiu Zheng Breakdown of academic impact, for papers by Michel Mohr Breakdown of academic impact, for papers by Sarah van Veen
Rankless by CCL
2026